Skip to main content

Transglutaminase activity is related to CAG repeat length in patients with Huntington’s disease

Abstract

Huntington’s disease (HD) is a neurodegenerative disorder associated with CAG repeat expansion. We measured transglutaminase (TGase) activity in lymphocytes from 35 HD patients and from healthy individuals to ascertain whether it was altered in this condition. TGase activity was above maximum control levels in 25% of HD patients; it was correlated with the age of the patient and inversely correlated with the CAG repeat length. These results suggest that: (1) HD could be biochemically heterogeneous, and (2) the length of the CAG repeat expansion/TGase ratio could be important in the manifestation of HD.

This is a preview of subscription content, access via your institution.

Author information

Affiliations

Authors

Additional information

Received: 25 March 1996 / Revised: 23 June 1996

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cariello, L., de Cristofaro, T., Zanetti, L. et al. Transglutaminase activity is related to CAG repeat length in patients with Huntington’s disease. Hum Genet 98, 633–635 (1996). https://doi.org/10.1007/s004390050273

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004390050273

Keywords

  • Healthy Individual
  • Control Level
  • Neurodegenerative Disorder
  • Repeat Length
  • Repeat Expansion